Insilico Medicine ("Insilico"), a clinical-stage, generative AI-driven drug discovery company, today announced the completion of first patient first dose in BETHESDA: a Phase IIa clinical trial of ...
Walk into any clinic these days, and you’ll hear the same line from young adults: “I think I have IBS—I saw a video ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback